UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

British journal of cancer, 2012-05, Vol.106 (11), p.1722-1727

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for venous thromboembolic events in cancer patients

Annals of oncology, 2006-02, Vol.17 (2), p.297-303

2006

Link zum Volltext

Verfügbarkeit prüfen

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Annals of oncology, 2010-02, Vol.21 (2), p.275-282

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas: a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

British journal of cancer, 2012-07, Vol.107 (2), p.280-286

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

British journal of cancer, 2014-03, Vol.110 (5), p.1155-1162

2014

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Annals of oncology, 2006-05, Vol.17 (5), p.866-873

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

Annals of oncology, 2002-02, Vol.13 (2), p.229-236

2002

Link zum Volltext

Verfügbarkeit prüfen

Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening

Neurology, 2005-03, Vol.64 (6), p.1076

2005

Link zum Volltext

Verfügbarkeit prüfen

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.331-339

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (3), p.233-241

2005

Link zum Volltext

Verfügbarkeit prüfen

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

Onkologie, 2002-12, Vol.25 (6), p.511

2002

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients

British journal of cancer, 2008-06, Vol.98 (12), p.1959-1965

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

British journal of cancer, 2008-11, Vol.99 (10), p.1579-1585

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors

Clinical cancer research, 1998-11, Vol.4 (11), p.2701-2708

1998

Link zum Volltext

Verfügbarkeit prüfen

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

European journal of cancer (1990), 2015-01, Vol.51 (1), p.27

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II and Pharmacologic Study of Weekly Oral Paclitaxel Plus Cyclosporine in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2002-12, Vol.20 (23), p.4508-4516

2002

Link zum Volltext

Verfügbarkeit prüfen

Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors

International journal of clinical pharmacology and therapeutics, 2002-12, Vol.40 (12), p.580

2002

Link zum Volltext

Verfügbarkeit prüfen

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors

Annals of oncology, 2004-08, Vol.15 (8), p.1284-1294

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Investigational new drugs, 2012-06, Vol.30 (3), p.1138-1143

2012

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib

Deutsche medizinische Wochenschrift, 2006-02, Vol.131 (5), p.214-218

2006

Link zum Volltext

Verfügbarkeit prüfen

High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (7), p.637-643

2004

Link zum Volltext

Verfügbarkeit prüfen

Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma

Journal of cancer research and clinical oncology, 2004-03, Vol.130 (3), p.153-160

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors

International journal of clinical pharmacology and therapeutics, 2003-12, Vol.41 (12), p.620

2003

Link zum Volltext

Verfügbarkeit prüfen

Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006

International journal of clinical pharmacology and therapeutics, 2003-12, Vol.41 (12), p.616

2003

Link zum Volltext

Verfügbarkeit prüfen

Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery

European journal of cardio-thoracic surgery, 1998-01, Vol.13 (1), p.57-65

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(190)

Sprache

Englisch
(161)
Deutsch
(29)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(118)
Life Sciences & Biomedicine
(93)
Science & Technology
(93)
Male
(77)
Oncology
(65)
Biological And Medical Sciences
(62)
Medical Sciences
(62)
Female
(60)
Middle Aged
(56)
Adult
(54)
Pharmacology. Drug Treatments
(47)
Aged
(44)
Antineoplastic Agents
(41)
Chemotherapy
(28)
Animals
(22)
Neoplasms - Drug Therapy
(22)
Tumors
(20)
Dose-Response Relationship, Drug
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Pharmacology & Pharmacy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

Risk factors for venous thromboembolic events in cancer patients

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas: a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Phase II and Pharmacologic Study of Weekly Oral Paclitaxel Plus Cyclosporine in Patients With Advanced Non–Small-Cell Lung Cancer

Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Bortezomib

High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer

Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma

A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors

Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006

Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery

Suchergebnisse filtern